Exact Mass: 368.0451
Exact Mass Matches: 368.0451
Found 364 metabolites which its exact mass value is equals to given mass value 368.0451,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Orotidylic acid
Orotidylic acid, also known as 5-(dihydrogen phosphate)orotidine or omp, is a member of the class of compounds known as pyrimidine ribonucleoside monophosphates. Pyrimidine ribonucleoside monophosphates are pyrimidine ribobucleotides with monophosphate group linked to the ribose moiety. Orotidylic acid is slightly soluble (in water) and a moderately acidic compound (based on its pKa). Orotidylic acid can be found in a number of food items such as coriander, summer savory, oriental wheat, and sourdough, which makes orotidylic acid a potential biomarker for the consumption of these food products. Orotidylic acid can be found primarily in prostate Tissue, as well as in human prostate tissue. Orotidylic acid exists in all living species, ranging from bacteria to humans. In humans, orotidylic acid is involved in a couple of metabolic pathways, which include glycine and serine metabolism and pyrimidine metabolism. Orotidylic acid is also involved in several metabolic disorders, some of which include dihydropyrimidinase deficiency, dihydropyrimidine dehydrogenase deficiency (DHPD), 3-phosphoglycerate dehydrogenase deficiency, and non ketotic hyperglycinemia. Moreover, orotidylic acid is found to be associated with prostate cancer. Orotidylic acid (OMP), is a pyrimidine nucleotide which is the last intermediate in the biosynthesis of uridine monophosphate. Decarboxylation by Orotidylate decarboxylase affords Uridine 5-phosphate which is the route to Uridine and its derivatives de novo and consequently one of the most important processes in nucleic acid synthesis (Dictionary of Organic Compounds). In humans, the enzyme UMP synthase converts OMP into uridine 5- monophosphate. If UMP synthase is defective, orotic aciduria can result. (Wikipedia). KEIO_ID O015; [MS2] KO009132 KEIO_ID O015
Spiro[benzofuran-2(3H),1-[2]cyclohexene]-7-chloro-4,6-dimethoxy-6-methyl-2-(methylthio)-3,4-dione
12-Deoxynogalonic acid
A member of the class of anthraquinones that is 10-oxo-3-(3-oxobutanoyl)-9,10-dihydroanthracen-2-yl]acetic acid bearing two additional hydroxy substituents at positions 4 and 5. An intermediate in the biosynthesis of nogalamycin.
Pyritinol
N - Nervous system > N06 - Psychoanaleptics > N06B - Psychostimulants, agents used for adhd and nootropics C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant
Velloquercetin
An extended flavonoid that consists of quercetin substituted by a 2-isopropenyldihydrofuran ring across positions 6 and 7.
Ketazolam
Ketazolam is only found in individuals that have used or taken this drug. It is a drug which is a benzodiazepine derivative. It possesses anxiolytic, anticonvulsant, sedative and skeletal muscle relaxant properties. Ketazolam is not approved for sale in the United States or Canada. Benzodiazepines share a similar chemical structure and their effects in humans are mainly produced by the allosteric modification of a specific kind of neurotransmitter receptor, the GABAA receptor, which increases the conductance of this inhibitory channel; this results in the various therapeutic effects as well as adverse effects of benzodiazepines. Binding of benzodiazepines to this receptor complex promotes binding of GABA, which in turn increases the conduction of chloride ions across the neuronal cell membrane. This increased conductance raises the membrane potential of the neuron resulting in inhibition of neuronal firing. In addition, different GABAA receptor subtypes have varying distributions within different regions of the brain and therefore control distinct neuronal circuits. Hence, activation of different GABAA receptor subtypes by benzodiazepines may result in distinct pharmacological actions. D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents N - Nervous system > N05 - Psycholeptics > N05B - Anxiolytics > N05BA - Benzodiazepine derivatives C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent
12alpha-Hydroxyerosone
12alpha-Hydroxyerosone is found in jicama. 12alpha-Hydroxyerosone is a constituent of Pachyrrhizus erosus (yam bean). Constituent of Pachyrrhizus erosus (yam bean). 12alpha-Hydroxyerosone is found in jicama and pulses.
Chlormerodrin
Chlormerodrin is a mercurial compound with toxic side effects that was previously used as a diuretic. The radiolabeled form has been used as a diagnostic and research tool. It is no longer used and has been replaced with new classes of diuretic drugs.
3'-O-Methyl-(-)-epicatechin-7-O-sulphate
3-O-Methyl-(-)-epicatechin-7-O-sulphate is an urinary and gut-derived metabolite of epicatechin.
Fentin
Fentin, also known as [sn(OH)PH3] or du-ter, belongs to the class of organic compounds known as benzene and substituted derivatives. These are aromatic compounds containing one monocyclic ring system consisting of benzene. Fentin is considered to be a practically insoluble (in water) and relatively neutral molecule. Fentin participates in a number of enzymatic reactions. In particular, fentin can be biosynthesized from triphenylstannane. Fentin can also be converted into fentin acetate. Fentin is a potentially toxic compound. Agricultural fungicide for potatoes, sugar beet, pecans and peanuts
3-Hydroxyhalazepam
Diacerein
M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C78281 - Agent Affecting Musculoskeletal System D000893 - Anti-Inflammatory Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Diacerein (Diacerhein), a interleukin-1 beta inhibitor, is a slow-acting medicine of the class anthraquinone used to treat joint diseases. Diacerein (Diacerhein), a interleukin-1 beta inhibitor, is a slow-acting medicine of the class anthraquinone used to treat joint diseases.
Pyrithioxin
N - Nervous system > N06 - Psychoanaleptics > N06B - Psychostimulants, agents used for adhd and nootropics C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant
Diacerein
4,5-diacetyloxy-9,10-dioxo-2-anthracenecarboxylic acid is an anthraquinone. Diacerein is a prodrug which is metabolized to rhein. It is currently approved in France for the treatment of osteoarthritis although the use of diacerein is restricted due to the side effects including severe diarrhea. Diacerein is under investigation for the treatment of Insulin Resistance, Diabetes Mellitus (Type 2), and Diabetes-Related Complications. M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C78281 - Agent Affecting Musculoskeletal System D000893 - Anti-Inflammatory Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Diacerein (Diacerhein), a interleukin-1 beta inhibitor, is a slow-acting medicine of the class anthraquinone used to treat joint diseases. Diacerein (Diacerhein), a interleukin-1 beta inhibitor, is a slow-acting medicine of the class anthraquinone used to treat joint diseases.
4,5-dihydro-6,8,10-trihydroxy-2-methyl-2,5-ethanoanthra[2,3-d]-1,3-dioxepin-7,12-dione
Candidusin B 2,2-Epoxy-3,6-dimethoxy-1,1,4,1-terphenyl-3,4,4,5-tetrol
Artoindonesianin P
An extended flavonoid that is 5a,6-dihydro-5H,7H-[1]benzofuro[3,4-bc]xanthen-7-one substituted by hydroxy groups at positions 1, 3, 8 and 10 and geminal methyl groups at position 5. It is isolated from the tree barks of Artocarpus lanceifolius and exhibits cytotoxicity against human murine leukemia cells.
3,4-Methylenedioxy-2-hydroxy-3,6-dimethoxy-[2,3:4,5]-furanochalcone
Cyclochampedol
UCT 1O72M3
12-Hydroxyerosone
O1-{[5-(3-Thienyl)-1,2,4-oxadiazol-3-yl]methyl}-4-(trifluoromethyl)benzene-1-carbohydroximamide
2,2-(1,4-Phenylene)bis(4H-benzo[d][1,3]oxazin-4-one)
2-(4-Hydroxyphenyl)-5,9-dihydroxy-8,8-dimethyl-9,10-dihydro-4H,8H-benzo[1,2-b:3,4-b]dipyran-4,10-dione
C1=C2C(=O)C3=CC(OC)=CC(OC)=C3C(=O)C2=C(O)C2=C1OC1OCCC12
4,5-di-O-acetylprunetin|5,4-diacetoxy-7-methoxyisoflavone|5-Acetoxy-3-(4-acetoxy-phenyl)-7-methoxy-chromen-4-on|5-acetoxy-3-(4-acetoxy-phenyl)-7-methoxy-chromen-4-one|prunetin diacetate
4,4-dimethoxypulvinic acid|4,4-dimethoxyvulpinic acid
2,4-Dichlor-3-hydroxy-7-methoxy-1,5,8-trimethyl-depsidon|2,4-Dichlor-3-hydroxy-7-methoxy-1,5,8-trimethyl-depsidon, Vicanicin|2,4-dichloro-3-hydroxy-8-methoxy-1,6,9-trimethyl-dibenzo[b,e][1,4]dioxepin-11-one|fulgoicin
3,7-di-O-acetylcalycosin|3,7-Diacetoxy-4-methoxyisoflavon|3-Hydroxy-formomonetin-diacetat|7,3-Diacetoxy-4-methoxy-isoflavon|7-acetoxy-3-(3-acetoxy-4-methoxy-phenyl)-chromen-4-one
3-Acetoxy-4-methoxy-6H-[1,3]dioxolo[5,6]benzofuro[3,2-c][1]benzopyran-6-one
2,7-dichloro-1,3,6-trihydroxy-8-methylxanthone-Tri-Me ether
(+)-aptosimon|(-)-Aptosimon|(1S,2R,5R,6R)-(-)-aptosimon|Genkdaphin
9-(3,4-dihydroxy-5-methoxy-phenyl)-7-hydroxy-6-methoxy-3H-naphtho[2,3-c]furan-1-one|Plicatinaphthalin|Plicatinaphthalin, 6-Hydroxy-2-(hydroxymethyl)-7-methoxy-4-(3,4-dihydroxy-5-methoxy-phenyl)-3-naphthalincarbonsaeurelacton
2-(2,4-Dihydroxyphenyl)-3,5-dihydroxy-8,8-dimethyl-8H-benzo[1,2-b:3,4-b]dipyran-4-one
(6S)-7-chloro-6-hydroxy-2,4,6-trimethoxy-6-methyl-3H-spiro[benzofuran-2,1-cyclohex[2]ene]-3,4-dione
(3R,4aR,13bS)-rel-(+)-1,2,3,4,4a,13b-Hexahydro-3,9,11,13-tetrahydroxy-anthra[2,3-b]benzofuran-7,12-dione
5,7-dihydroxychromone-7-O-beta-D-glucuronide methyl ester|7-(methyl glucuronide)-5-hydroxychromone
14-Hydroxy-Chloromonilinic acid B|chloromonilinic acid A
2-Sulfate-3-(3,4-Dihydroxyphenyl)-2,3-dihydro-2-hydroxy-1,4-benzodioxin-6-carboxaldehyde
2-O-caffeoylisocitric acid 6-methyl ester|E-2-(3-(3,4-dihydroxyphenyl)prop-2-enoyloxy)-3-(methoxycarbonyl)pentanedioic acid
(3E)-4-(1,3-benzodioxol-5-ylmethyl)-3-(1,3-benzodioxol-5-ylmethylene)dihydro-4-hydroxyfuran-2(3H)-one
10H-3,10a-Epidithiopyrazino(1,2-a)indole-1,4-dione, 2,3,5a,6-tetrahydro-6-hydroxy-3-(hydroxymethyl)-2-methyl-, monoacetate (ester)
3-(1,3-benzodioxol-5-yl)-1-(6-hydroxy-4,7-dimethoxy-1-benzofuran-5-yl)prop-2-en-1-one
Spiro[benzofuran-2(3H),1-[2]cyclohexene]-3,4-dione, 7-chloro-5-hydroxy-2,4,6-trimethoxy-6-methyl-, [1S-(1.alpha.,5.beta.,6.beta.)]-
3-hydroxy-2-[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy-3-methoxycarbonylpentanedioic acid
Cys Cys Gly Ser
Cys Cys Ser Gly
Cys Gly Cys Ser
Cys Gly Ser Cys
Cys Ser Cys Gly
Cys Ser Gly Cys
Gly Cys Cys Ser
Gly Cys Ser Cys
Gly Ser Cys Cys
Ser Cys Cys Gly
Ser Cys Gly Cys
Ser Gly Cys Cys
Anseren
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents N - Nervous system > N05 - Psycholeptics > N05B - Anxiolytics > N05BA - Benzodiazepine derivatives C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent
2-Deoxy-4-O-[(2E)-3-(4-hydroxyphenyl)-2-propenoyl]-3-C-(methoxycarbonyl)pentaric acid
[3,3,4,4,5,6,6,6-octafluoro-5-(trifluoromethyl)hexyl] prop-2-enoate
tert-Butyl 4-(4-bromo-2-formylphenyl)piperazine-1-carboxylate
4-(3-BROMO-BENZOYL)-PIPERAZINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER
3-[3-(4-BROMO-PHENYL)-1-PHENYL-1H-PYRAZOL-4-YL]-ACRYLIC ACID
6-chloro-1-(4-methoxybenzyl)-4-(trifluoromethyl)quinazolin-2(1H)-one
Disodium uridine 5-phosphate
Uridine 5'-monophosphate disodium salt is component used for RNA synthesis. Uridine 5'-monophosphate disodium salt is component used for RNA synthesis.
10-(4-chlorophenyl)-7-nitropyrimido[4,5-b]quinoline-2,4-dione
Adenosine 5′-monophosphoramidate sodium
Adenosine 5′-monophosphoramidate sodium is an adenosine derivative and can be used as an intermediate for nucleotide synthesis. Adenosine 5′-monophosphoramidate has a significant effect on the accumulation of cyclic AMP[1]. Adenosine 5′-monophosphoramidate sodium is an adenosine derivative and can be used as an intermediate for nucleotide synthesis. Adenosine 5′-monophosphoramidate has a significant effect on the accumulation of cyclic AMP[1].
2-Amino-5-bromo-N-cyclohexyl-N-methylbenzylamine Dihydrochloride
4-(4-BROMO-BENZOYL)-PIPERAZINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER
n,n-difluoro-2,2-bipyridinium bis(tetrafluoroborate)
Benzenesulfonamide,N,N-1,2-ethanediylbis[4-methyl-
4-(3-CHLORO-4-FLUOROPHENYL)-1,2-DIMETHYL-5-(QUINOXALIN-6-YL)-1H-PYRAZOL-3(2H)-ONE
4-(4-BROMO-2-ETHYL-BENZENESULFONYL)-PIPERAZINE HYDROCHLORIDE
Spiro[isobenzofuran-1(3H),9-[9H]xanthen]-3-one,3,6-dichloro-
N-(6-bromo-2,3,4,9-tetrahydro-1H-carbazol-1-yl)benzamide
2,3-Diphenyl-5-(4-chlorophenyl)tetrazolium Chloride
ETHYL 2-(2-([(4-CHLOROPHENYL)SULFONYL]METHYL)PHENOXY)ACETATE
[1-(3-BroMo-benzenesulfonyl)-piperidin-3-yl]-Methyl-aMine hydrochloride
1-Sulfobutyl-3-MethyliMidazoliuM trifluoroMethansulfonate
PD168393
C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor
Firibastat
D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents C471 - Enzyme Inhibitor > C783 - Protease Inhibitor
Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione
2-Quinolinecarboxylic acid, 7-chloro-1,2,3,4-tetrahydro-4-(2-oxo-1-phenyl-3-pyrrolidinylidene)-, (2R,4E)-
3-(4-propan-2-ylphenyl)sulfonyl-1H-triazolo[1,5-a]quinazolin-5-one
3-(4-methoxyphenyl)-4-oxo-4H-chromene-5,7-diyl diacetate
4-Fluorobenzoic acid 4-[(5-phenyl-1,3,4-oxadiazol-2-yl)thio]but-2-ynyl ester
methyl 2-{1-[3-chloro-5-(trifluoromethyl)-2-pyridinyl]-1H-indol-3-yl}acetate
1-(2,6-Dichlorobenzyl)-5-(4-methylphenyl)-2-oxo-1,2-dihydro-3-pyridinecarbonitrile
1-allyl-N-(4-chlorobenzyl)-4-hydroxy-2-oxo-1,2-dihydroquinoline-3-carboxamide
2-[3-Chloro-5-(trifluoromethyl)-2-pyridinyl]-5-methyl-4-(4-methylphenyl)-1,2,4-triazol-3-one
2-(2,7-difluoro-6-hydroxy-3-oxo-3H-xanthen-9-yl)benzoic acid
Spiro[benzofuran-2(3H),1-[2]cyclohexene]-3,4-dione, 7-chloro-4,6-dimethoxy-6-methyl-2-(methylthio)-
N-Hydroxy-5-[(3-Phenyl-5,6-Dihydroimidazo[1,2-A]pyrazin-7(8h)-Yl)carbonyl]thiophene-2-Carboxamide
hydroxy(oxo)(2-{(1S)-2,2,2-trifluoro-1-[2-(trimethylarsonio)ethoxy]ethyl}phenyl)ammonium
2-(beta-D-glucopyranosyluronate)-D-glucuronate(2-)
[3-Amino-6-(2-thienyl)-4-(trifluoromethyl)thieno[2,3-b]pyridin-2-yl](cyclopropyl)methanone
4-(2-chlorophenyl)-3-(5-methyl-3-phenyl-4-isoxazolyl)-1H-1,2,4-triazole-5-thione
1-[3-[4-[(1-Methyl-5-tetrazolyl)thio]-5-thieno[2,3-d]pyrimidinyl]phenyl]ethanone
5-[[(5-Ethyl-[1,2,4]triazino[5,6-b]indol-3-yl)thio]methyl]-2-furancarboxylic acid methyl ester
N-[(E)-1-(2,4-dichlorophenyl)methylidene]-N-phenyl-2-pyridinecarbohydrazonamide
(6E)-6-{[5-(benzylthio)-2-furyl]methylene}-5-imino-5,6-dihydro-7H-[1,3,4]thiadiazolo[3,2-a]pyrimidin-7-one
2-[[(5-Anilino-1,3,4-thiadiazol-2-yl)thio]methyl]isoindole-1,3-dione
5-ethyl-4-oxo-N-(thiophen-2-ylmethyl)-2-thieno[3,2-c]quinolinecarboxamide
1-(4-Chlorophenyl)-2-[(5-methyl-[1,2,4]triazino[5,6-b]indol-3-yl)thio]ethanone
N-(benzenesulfonyl)-N-(4-methoxyphenyl)-3-pyridinecarboxamide
4-O-alpha-D-galactopyranuronosyl-D-galactopyranuronate
N-(2-methylsulanyl-1,3-benzothiazol-6-yl)-2-(triluoromethyl)benzamide
1-Tert-butyl-5-[(2,4-dichloro-5-fluorophenyl)methyl]-4-pyrazolo[3,4-d]pyrimidinone
4-bromo-2-[(E)-[(5-phenylpyrimidin-2-yl)hydrazinylidene]methyl]phenol
1-[2-[4-[(1-Methyl-5-tetrazolyl)thio]-5-thieno[2,3-d]pyrimidinyl]phenyl]ethanone
2-[(Z)-1-chloro-2-(3-fluorophenyl)ethenyl]-7-(trifluoromethyl)-3H-quinazolin-4-one
[5,7-Dihydroxy-2-(3-hydroxyphenyl)-4-oxo-2,3-dihydrochromen-3-yl] hydrogen sulate
[4-[2,3-Dioxo-3-(2,4,6-trihydroxyphenyl)propyl]phenyl] hydrogen sulate
[3,4,5-Trihydroxy-6-(2,4,6-trihydroxyphenyl)oxan-2-yl]methyl hydrogen sulate
[5,7-Dihydroxy-2-(4-hydroxyphenyl)-4-oxo-2,3-dihydrochromen-3-yl] hydrogen sulate
3,4,5-Trihydroxy-6-[3-(hydroxymethyl)-1-oxoisochromen-7-yl]oxyoxane-2-carboxylic acid
[3,5,6-trihydroxy-2-(3-methoxyphenyl)-3,4-dihydro-2H-chromen-7-yl] hydrogen sulfite
3-hydroxy-2-[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy-3-methoxycarbonylpentanedioic acid
(5R,6R)-1,5,6-trihydroxy-3-(hydroxymethyl)-8-methoxy-5,6-dihydrobenzo[a]anthracene-7,12-dione
(1S,5S)-averufin
An organic heteropentacyclic compound that is 3,4,5,6-tetrahydro-2H-2,6-epoxyanthra[2,3-b]oxocine-8,13-dione substituted at position 2 by a methyl group and at positions 7, 9 and 11 by hydroxy groups (the S,S-diastereomer)
alpha-D-GalpA-(1->4)-alpha-D-GalpA(2-)
An alpha-D-GalpA-(1->4)-D-GalpA(2-) in which both galacturonate units have alpha-D configuration.
Norsolorinate(2-)
An organic anion obtained by selective deprotonation of the 2- and 7-hydroxy groups of norsolorinic acid.
Orotidine 5-phosphate
A pyrimidine ribonucleoside 5-monophosphate having 6-carboxyuracil as the nucleobase.
versicolorone tetracyclic form
The tetracyclic anthrafuran form of versicolorone.
SLC26A3-IN-2
SLC26A3-IN-2 is an orally active inhibitor of anion exchanger protein SLC26A3 (IC50=360 nM). SLC26A3 belongs to solute carrier (SLC) proteins, and the SLC26 family. SLC26 family has broad anion specificity for chloride, bicarbonate, sulfate and oxalate. SLC26A3 down-regulates in adenoma, DRA, involves in in intestinal absorption of chloride and oxalate. The loss of SLC26A3 function mutations is associated with chloride-losing diarrhea[1].
(1s,13s)-10-hydroxy-16,17-dimethoxy-2,7,20-trioxapentacyclo[11.8.0.0³,¹¹.0⁴,⁸.0¹⁴,¹⁹]henicosa-3,5,8,10,14(19),15,17-heptaen-12-one
methyl (1s,4s,8r,10s,11e,14s)-11-[(4-hydroxyphenyl)methylidene]-12-oxo-7,9,13-trioxatetracyclo[6.5.1.0¹,¹⁰.0⁴,¹⁴]tetradeca-2,5-diene-5-carboxylate
[(3as,4r,9r,10as)-5,10,10-trihydroxy-4-(hydroxymethyl)-2,6-diimino-hexahydropyrrolo[1,2-c]purin-9-yl]oxidanesulfonic acid
1-hydroxy-3-(4-hydroxyphenyl)-4-methoxy-6-(4-methoxyphenyl)-7-oxabicyclo[4.1.0]hept-3-ene-2,5-dione
(1r,13r)-13-hydroxy-16,17-dimethoxy-2,7,20-trioxapentacyclo[11.8.0.0³,¹¹.0⁴,⁸.0¹⁴,¹⁹]henicosa-3,5,8,10,14(19),15,17-heptaen-12-one
6-{[2-(2,4-dihydroxy-6-methylbenzoyl)-3-hydroxyphenyl]methyl}-4-hydroxypyran-2-one
(17s)-7,20-dihydroxy-17-(2-hydroxypropan-2-yl)-10,12,16-trioxapentacyclo[11.7.0.0³,¹¹.0⁴,⁹.0¹⁵,¹⁹]icosa-1(20),3(11),4(9),5,7,13,15(19)-heptaen-2-one
3,11,21,22-tetraoxaheptacyclo[10.9.1.1¹,⁶.1¹²,¹⁶.0²,⁴.0¹⁰,²⁴.0²⁰,²³]tetracosa-6(24),7,9,16(23),17,19-hexaene-5,7,15-triol
(1r,2s,6br,12bs)-1,2,4,6b,10-pentahydroxy-2,7,8,12b-tetrahydro-1h-perylene-3,9-dione
1,3,7,8-tetrahydroxy-11-(2-methylprop-1-en-1-yl)-11h-5,10-dioxatetraphen-12-one
(5r,6r)-1,5,6-trihydroxy-3-(hydroxymethyl)-8-methoxy-5,6-dihydrotetraphene-7,12-dione
(4'r,5's,6's,7's)-5,5',6',7',9'-pentahydroxy-3'-oxaspiro[naphthalene-1,2'-tricyclo[6.3.1.0⁴,¹²]dodecane]-1'(12'),8',10'-trien-4-one
7,8-dimethoxy-3,4-dihydro-3',10'-dioxaspiro[1,5-benzodioxepine-2,4'-tricyclo[7.3.0.0²,⁶]dodecane]-1',6',8',11'-tetraen-5'-one
(2e)-3-chloro-3-{5-hydroxy-3-[(1s)-1-hydroxy-2-methoxy-2-oxoethyl]-7-methyl-4-oxochromen-2-yl}prop-2-enoic acid
11-(3,4-dihydroxyphenyl)-10,13-dimethoxy-8-oxatricyclo[7.4.0.0²,⁷]trideca-1(9),2(7),3,5,10,12-hexaene-4,5-diol
(3r,3as,6r,6ar)-3-(2h-1,3-benzodioxol-4-yl)-6-(2h-1,3-benzodioxol-5-yl)-tetrahydro-3h-furo[3,4-c]furan-1-one
3-[4-(acetyloxy)phenyl]-7-methoxy-4-oxochromen-5-yl acetate
2,5,7-trihydroxy-3-methoxy-2-methyl-3,4-dihydrotetracene-1,6,11-trione
7,9,20-trihydroxy-17-methyl-16,21-dioxapentacyclo[15.3.1.0²,¹⁵.0⁴,¹³.0⁶,¹¹]henicosa-2,4(13),6,8,10,14-hexaene-5,12-dione
5,9-dihydroxy-2-(4-hydroxyphenyl)-8,8-dimethyl-9h-pyrano[2,3-h]chromene-4,10-dione
6aα,12aα-12a-hydroxyelliptone
{"Ingredient_id": "HBIN012151","Ingredient_name": "6a\u03b1,12a\u03b1-12a-hydroxyelliptone","Alias": "NA","Ingredient_formula": "C20H16O7","Ingredient_Smile": "COC1=C(C=C2C(=C1)C3(C(CO2)OC4=C(C3=O)C=CC5=C4C=CO5)O)OC","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10066","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
(?)-aptosimon
{"Ingredient_id": "HBIN016532","Ingredient_name": "(?)-aptosimon","Alias": "NA","Ingredient_formula": "C20H16O7","Ingredient_Smile": "C1C2C(C(O1)C3=CC4=C(C=C3)OCO4)C(=O)OC2C5=CC6=C(C=C5)OCO6","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1537","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
